Clinical Trial Update: SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD) [NA]

View source ↗

Summary

This document provides a clinical trial update for SCI-210 in children and young adults with autism spectrum disorder. The trial aims to evaluate safety, tolera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• SCI-210

Snippet

Sponsor: Neurothera Labs Inc. | Conditions: Autism Spectrum Disorder (ASD) | NA | Status: RECRUITING